Company profile

Future of Health Net

#
Rank
732
| Quantumrun Global 1000

Health Net, Inc. is a US healthcare insurance provider. HMO, POS, insured PPO and government contracts subsidiaries offers health benefits to an estimated 5.9 million individuals in all 50 states and the District of Columbia through Medicaid, Veterans Affairs programs, group, individual, Medicare, and Tricare. Health Net's behavioral health services subsidiary, MHN, offers behavioral health, substance abuse, and employee assistance programs (EAPs) to an estimated 7.3 million individuals in various states, including its own health plan members. The company's subsidiaries also provide managed Healthcare products related to prescription drugs and offer managed Healthcare product coordination for multi-region employers and administrative services for medical groups and self-funded benefits programs. St. Louis-based Centene announced in July that it plans to purchase Health Net for $6.8 billion. The company is headquartered in St. Louis, MO. Woodland Hills, Los Angeles, California.

Home Country:
Sector:
Industry:
Healthcare - Insurance and Managed Care
Website:
Founded:
1979
Global employee count:
9300
Domestic employee count:
Number of domestic locations:

Financial Health

3y average revenue:
$15126086500 USD
3y average expenses:
$14798868500 USD
Funds in reserve:
$996854000 USD

Asset Performance

  1. Product/Service/Dept. name
    Health plan services premiums
    Product/Service revenue
    15553348000
  2. Product/Service/Dept. name
    Government contracts
    Product/Service revenue
    628451000
  3. Product/Service/Dept. name
    Net investment income
    Product/Service revenue
    55494000

Innovation assets and Pipeline

All company data collected from its 2015 annual report and other public sources. The accuracy of this data and the conclusions derived from them depend on this publicly accessible data. If a data point listed above is discovered to be inaccurate, Quantumrun will make the necessary corrections to this live page. 

DISRUPTION VULNERABILITY

Belonging to the healthcare sector means this company will be affected directly and indirectly by a number of disruptive opportunities and challenges over the coming decades. While described in detail within Quantumrun’s special reports, these disruptive trends can be summarized along the following broad points:

*First off, the late 2020s will see the Silent and Boomer generations enter deep into their senior years. Representing nearly 30-40 per cent of the global population, this combined demographic will represent a significant strain on the health systems of developed nations. *However, as an engaged and wealthy voting block, this demographic will actively vote for increased public spending on subsidized health services (hospitals, emergency care, nursing homes, etc.) to support them in their greying years.

*The economic strain caused this massive senior citizen demographic will encourage developed nations to fast-track the testing and approval process for new drugs, surgeries and treatment protocols that may improve the overall physical and mental health of patients to a point where they can lead independent lives outside of the health care system.

*This increased investment into the health care system will include a greater emphasis on preventative medicine and treatments.

*By the early 2030s, the most profound preventative health care treatment will become available: treatments to stunt and later reverse the effects of aging. These treatments will be provided annually and, over time, will become affordable to the masses. This health revolution will result in a reduced usage and strain on the overall health care system—since younger people/bodies use less health care resources, on average, than people in older, sicker bodies.

*Increasingly, we will use artificial intelligence systems diagnose patients and robots to manage intricate surgeries.

*By the late 2030s, technological implants will correct any physical injury, while brain implants and memory erasure drugs will cure most any mental trauma or illness.

*By the mid-2030s, all medicines will be customized to your unique genome and microbiome.

COMPANY’S FUTURE PROSPECTS

Company Headlines